- Home
- HROW vs DQ Comparison
HROW vs DQ Comparison
Compare HROW & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HROW | DQ |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | HROW | DQ |
|---|---|---|
| Price | $34.10 | $23.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $71.14 | $28.91 |
| AVG Volume (30 Days) | ★ 924.6K | 552.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $44.68 | $70.27 |
| Revenue Next Year | $40.71 | $34.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.85 | $12.41 |
| 52 Week High | $54.98 | $36.59 |
Technical Indicators
Market Signals| Indicator | HROW | DQ |
|---|---|---|
| Relative Strength Index (RSI) | 27.80 | 42.60 |
| Support Level | $30.55 | $22.53 |
| Resistance Level | $40.64 | $23.91 |
| Average True Range (ATR) | 2.54 | 1.11 |
| MACD | -1.45 | 0.06 |
| Stochastic Oscillator | 2.31 | 25.46 |
Price Performance
Historical ComparisonAbout HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About DQ DAQO New Energy Corp.
Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.